批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/01/04 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/04/29 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/08/09 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/26 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2003/05/02 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/11/24 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/03/31 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/01/08 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/01/16 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/11/20 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/07/28 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/07/28 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/03/08 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/03/08 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1995/07/07 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/06/27 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/06/02 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/03/07 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/07/09 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/04/22 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
1989/05/17 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/09/13 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1988/03/16 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/06/04 |
SUPPL-12(补充) |
Approval |
Labeling |
|
|
|
1985/09/17 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1984/10/22 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1982/11/18 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1978/06/14 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/11/10 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1977/02/09 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1977/02/09 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/10/01 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 剂型/给药途径:TABLET;ORAL-21 规格:0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
017876 |
001 |
NDA |
LOESTRIN 21 1/20 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
TABLET;ORAL-21 |
0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
TEVA BRANDED PHARM |